NanoVibronix shares are trading higher after the company reported outcomes from a UroShield study conducted at the University of Southampton in the U.K.
Portfolio Pulse from Benzinga Newsdesk
NanoVibronix has reported positive outcomes from a UroShield study conducted at the University of Southampton in the U.K. This has led to an increase in the company's share prices.
August 30, 2023 | 1:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
NanoVibronix's shares are trading higher following positive outcomes from a UroShield study.
The positive outcomes from the UroShield study have increased investor confidence in NanoVibronix, leading to a rise in the company's share prices. This indicates a positive short-term impact on the company's stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100